Filing Details
- Accession Number:
- 0000905718-19-000779
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-09-19 17:45:35
- Reporting Period:
- 2019-09-13
- Accepted Time:
- 2019-09-19 17:45:35
- Original Submission Date:
- 2019-09-16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1498382 | Delmar Pharmaceuticals Inc. | DMPI | Pharmaceutical Preparations (2834) | 990360497 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1569585 | K John Bell | 12707 High Bluff Dr. Suite 200 San Diego CA 92130 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-09-13 | 35,000 | $0.68 | 35,000 | No | 4 | P | Indirect | Held by Registered Retirement Income Fund |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | Held by Registered Retirement Income Fund |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 9,701 | Indirect | Held by Onbelay Capital Inc. |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6551 to $0.68 per share, inclusive. The reporting person undertakes to provide to DelMar Pharmaceuticals, Inc., any security holder of DelMar Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
- This Form 4/A amends the Form 4 filed by the reporting person on September 16, 2019 solely to amend the disclosure of the shares beneficially owned as of such date by the reporting person.
Billionaire Hedge Funds
